{"nct_id":"NCT02130466","title":"A Study of the Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With Trametinib and Dabrafenib in Participants With Advanced Melanoma (MK-3475-022/KEYNOTE-022)","status":"COMPLETED","status_verified_date":"2022-06","start_date":"2014-05-29","start_date_type":"ACTUAL","primary_completion_date":"2021-07-14","primary_completion_date_type":"ACTUAL","completion_date":"2021-07-14","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["MRK"]}